NCT00864032View on ClinicalTrials.gov

Trial of Neoadjuvant Conformal Radiotherapy Plus Sorafenib for Patients With Soft Tissue Sarcoma of the Extremity and Body Wall

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Sorafenib

400mg twice daily

Trial Locations (1)

95817

University of california, Davis Medical Center, Sacramento

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

University of California, Davis

OTHER